More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-11 of 11 results

  • luxturnahcp.com
LUXTURNA is a gene augmentation therapy that uses an AAV2 viral vector to deliver the human RPE65 cDNA into the RPE cells and induces them to produce a functional RPE65 enzyme. 1... AAV2 is used in the delivery of LUXTURNA. AAV2 efficiently..
Relevance: 87.57764
  • eyewant2know.com
Links to sites outside of Spark Therapeutics are provided as a resource to the viewer. Spark Therapeutics is not responsible for and has no control over the content of linked sites... If you are a patient or caregiver interested in genetic testing,..
Relevance: 87.57764
  • resolutestudy.com
  • 1
Spark and Spark Therapeutics and Design are registered trademarks of Spark Therapeutics, Inc., in the United States and other countries. RESOLUTE SM and RESOLUTE SM and Design are service marks of Spark Therapeutics, Inc., in the United States.....
Relevance: 86.95812
  • prodadminportal.azurewebsites.net
  • 2
Spark Therapeutics, Inc. and our distinguished faculty cordially invite you to participate in the educational program, A Gene Therapy Advancement in the Treatment of IRD... For questions about the program, please contact us at..
Relevance: 86.95812
  • mysparkgeneration.com
  • 1
  • 2
We understand that living with a genetic disease can be challenging for patients and their caregivers. Your determination-and the determination of others like you-motivates the work that we do. Here at Spark® Therapeutics, we take a patient-centric..
Relevance: 86.40428
  • sparktx.com
  • 2
  • 2
Our mission at Spark Therapeutics is to unlock the power of gene therapy to accelerate healthcare transformation. We have built a fully integrated company, combining our proprietary adeno-associated viral (AAV) gene therapy platform with excellence..
Relevance: 86.28015
  • luxturnahcp.com
Retinal abnormalities may occur during or following the subretinal injection of LUXTURNA, including macular holes, foveal thinning, loss of foveal function, foveal dehiscence, and retinal hemorrhage. Monitor and manage these retinal abnormalities..
Relevance: 86.22585
  • www.sparktxemailresources.com
This site provides processes and guidelines for deploying Spark marketing emails and content relationship management programs through Act-On...
Relevance: 86.160576
  • www.resolutestudy.com
The RESOLUTE study is the first in human clinical research study evaluating investigational product SPK-3006 in late-onset Pompe disease (LOPD) patients... Spark and Spark Therapeutics and Design are registered trademarks of Spark Therapeutics,..
Relevance: 83.0949
Relevance: 46.04713
  • luxturna.com
  • 1
LUXTURNA is the first prescription gene therapy product to help improve functional vision in patients with an inherited retinal disease (IRD) due to a mutation in their RPE65 gene. It is a one-time gene therapy that has the potential to restore the..
Relevance: 22.073559